Anixa Biosciences (ANIX) Return on Assets (2011 - 2026)
Anixa Biosciences' (ANIX) quarterly Return on Assets came in at 4.78% in Q2 2026, down 475.0% YoY from 1.27% in Q2 2025, and down 9.0% on a QoQ basis from 4.38% in Q4 2025.
Anixa Biosciences (ANIX) Return on Assets (2011 - 2026) Analysis & Trends
Anixa Biosciences (ANIX) has 16 years of Return on Assets data on file, last reported at 4.78% in Q2 2026.
- Quarterly Return on Assets fell 475.0% year-over-year to 4.78% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 4.78% (down 475.0% YoY) and the FY2025 annual result came in at 3.92%, down 306.0% from the prior year.
- Return on Assets retreated to 4.78% in Q2 2026, from 4.38% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.01% in Q3 2022 to a low of 14.61% in Q3 2024.
- A 5-year average of 6.21% and a median of 4.78% in 2026 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2023 — Return on Assets plunged 1093 bps — and 2025, when it jumped 1458 bps.
- Tracing ANIX's Return on Assets over 5 years: stood at 9.41% in 2022, then tumbled by 41 bps to 13.25% in 2023, then jumped by 100 bps to 0.03% in 2024, then sank by 15677 bps to 4.38% in 2025, then fell by 9 bps to 4.78% in 2026.
- The last three Return on Assets figures came in at 4.78% (Q2 2026), 4.38% (Q4 2025), and 0.03% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Anixa Biosciences | 123.62 Mn | 123.62 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -4.78% |
| Oct 31, 2025 | -4.38% |
| Jul 31, 2025 | -0.03% |
| Apr 30, 2025 | -0.03% |
| Jan 31, 2025 | -0.03% |
| Oct 31, 2024 | -0.03% |
| Jul 31, 2024 | -14.61% |
| Apr 30, 2024 | -13.89% |
| Jan 31, 2024 | -13.57% |
| Oct 31, 2023 | -13.25% |
| Jul 31, 2023 | -10.94% |
| Apr 30, 2023 | -10.60% |
| Jan 31, 2023 | -10.09% |
| Oct 31, 2022 | -9.41% |
| Jul 31, 2022 | -0.01% |
| Apr 30, 2022 | -0.01% |
| Jan 31, 2022 | -0.01% |
| Oct 31, 2021 | -0.01% |
| Jul 31, 2021 | -0.01% |
| Apr 30, 2021 | -0.01% |